IGM Biosciences, Inc. Operating Expenses
IGM Biosciences, Inc. reported Operating Expenses of $47.36 million for the 3-month period ending 2025-06-30, per its 10-Q filed 2025-07-31.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2025-07-31
- IGM Biosciences, Inc. operating expenses for the quarter ending 2025-06-30 was $47.36M, a 9.98% decline year-over-year.
- IGM Biosciences, Inc. operating expenses for the quarter ending 2025-03-31 was $55.27M, a 1.70% increase year-over-year.
- IGM Biosciences, Inc. operating expenses for the quarter ending 2024-12-31 was $39.39M, a 40.11% decline year-over-year.
- IGM Biosciences, Inc. operating expenses for the quarter ending 2024-09-30 was $64.90M, a 3.52% decline year-over-year.
- IGM Biosciences, Inc. operating expenses for fiscal 2024 was $211.26M, a 20.46% decline from fiscal 2023.
- IGM Biosciences, Inc. operating expenses for fiscal 2023 was $265.59M, a 15.97% increase from fiscal 2022.
- IGM Biosciences, Inc. operating expenses for fiscal 2022 was $229.03M, a 38.53% increase from fiscal 2021.
- IGM Biosciences, Inc. operating expenses for fiscal 2021 was $165.32M, a 98.51% increase from fiscal 2020.
| Period end | Operating Expenses 3 month | Operating Expenses 6 month | Operating Expenses 9 month | Operating Expenses 12 month |
|---|---|---|---|---|
| 2025-06-30 | $47.36M 10-Q · filed 2025-07-31 | $102.64M 10-Q · filed 2025-07-31 | $142.03M derived: sum of 3 quarters · filed 2025-07-31 | $206.93M derived: sum of 4 quarters · filed 2025-07-31 |
| 2025-03-31 | $55.27M 10-Q · filed 2025-05-13 | $94.67M derived: sum of 2 quarters · filed 2025-05-13 | $159.57M derived: sum of 3 quarters · filed 2025-05-13 | $212.18M derived: sum of 4 quarters · filed 2025-07-31 |
| 2024-12-31 | $39.39M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-06 | $104.30M derived: sum of 2 quarters · filed 2025-03-06 | $156.91M derived: sum of 3 quarters · filed 2025-07-31 | $211.26M 10-K · filed 2025-03-06 |
| 2024-09-30 | $64.90M 10-Q · filed 2024-11-08 | $117.51M derived: sum of 2 quarters · filed 2025-07-31 | $171.87M 10-Q · filed 2024-11-08 | $237.64M derived: sum of 4 quarters · filed 2025-07-31 |
| 2024-06-30 | $52.61M 10-Q · filed 2025-07-31 | $106.96M 10-Q · filed 2025-07-31 | $172.73M derived: sum of 3 quarters · filed 2025-07-31 | $240.00M derived: sum of 4 quarters · filed 2025-07-31 |
| 2024-03-31 | $54.35M 10-Q · filed 2025-05-13 | $120.12M derived: sum of 2 quarters · filed 2025-05-13 | $187.39M derived: sum of 3 quarters · filed 2025-05-13 | $256.05M derived: sum of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | $65.77M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-06 | $133.04M derived: sum of 2 quarters · filed 2025-03-06 | $201.69M derived: sum of 3 quarters · filed 2025-03-06 | $265.59M 10-K · filed 2025-03-06 |
| 2023-09-30 | $67.27M 10-Q · filed 2024-11-08 | $135.93M derived: sum of 2 quarters · filed 2024-11-08 | $199.82M 10-Q · filed 2024-11-08 | $256.46M derived: sum of 4 quarters · filed 2025-03-06 |
| 2023-06-30 | $68.66M 10-Q · filed 2024-08-14 | $132.55M 10-Q · filed 2024-08-14 | $189.19M derived: sum of 3 quarters · filed 2025-03-06 | $250.03M derived: sum of 4 quarters · filed 2025-03-06 |
| 2023-03-31 | $63.90M 10-Q · filed 2024-05-08 | $120.53M derived: sum of 2 quarters · filed 2025-03-06 | $181.38M derived: sum of 3 quarters · filed 2025-03-06 | $240.97M derived: sum of 4 quarters · filed 2025-03-06 |
| 2022-12-31 | $56.64M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-06 | $117.48M derived: sum of 2 quarters · filed 2025-03-06 | $177.07M derived: sum of 3 quarters · filed 2025-03-06 | $229.03M 10-K · filed 2025-03-06 |
| 2022-09-30 | $60.84M 10-Q · filed 2023-11-13 | $120.43M derived: sum of 2 quarters · filed 2023-11-13 | $172.39M 10-Q · filed 2023-11-13 | $223.07M derived: sum of 4 quarters · filed 2024-03-07 |
| 2022-06-30 | $59.59M 10-Q · filed 2023-08-03 | $111.55M 10-Q · filed 2023-08-03 | $162.23M derived: sum of 3 quarters · filed 2024-03-07 | $206.43M derived: sum of 4 quarters · filed 2024-03-07 |
| 2022-03-31 | $51.96M 10-Q · filed 2023-05-12 | $102.64M derived: sum of 2 quarters · filed 2024-03-07 | $146.84M derived: sum of 3 quarters · filed 2024-03-07 | $185.57M derived: sum of 4 quarters · filed 2024-03-07 |
| 2021-12-31 | $50.68M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-07 | $94.88M derived: sum of 2 quarters · filed 2024-03-07 | $133.62M derived: sum of 3 quarters · filed 2024-03-07 | $165.32M 10-K · filed 2024-03-07 |
| 2021-09-30 | $44.20M 10-Q · filed 2022-11-03 | $82.94M derived: sum of 2 quarters · filed 2022-11-03 | $114.64M 10-Q · filed 2022-11-03 | $139.38M derived: sum of 4 quarters · filed 2022-11-03 |
| 2021-06-30 | $38.74M 10-Q · filed 2022-08-08 | $70.44M 10-Q · filed 2022-08-08 | $95.18M derived: sum of 3 quarters · filed 2022-08-08 | $115.74M derived: sum of 4 quarters · filed 2022-08-08 |
| 2021-03-31 | $31.71M 10-Q · filed 2022-05-09 | $56.45M derived: sum of 2 quarters · filed 2022-05-09 | $77.01M derived: sum of 3 quarters · filed 2022-05-09 | $96.41M derived: sum of 4 quarters · filed 2022-05-09 |
| 2020-12-31 | $24.74M 10-K · filed 2021-03-30 | $45.30M derived: sum of 2 quarters · filed 2021-11-04 | $64.71M derived: sum of 3 quarters · filed 2021-11-04 | $83.28M 10-K · filed 2023-03-30 |
| 2020-09-30 | $20.56M 10-Q · filed 2021-11-04 | $39.97M derived: sum of 2 quarters · filed 2021-11-04 | $58.54M 10-Q · filed 2021-11-04 | $74.48M derived: sum of 4 quarters · filed 2021-11-04 |
| 2020-06-30 | $19.41M 10-Q · filed 2021-08-09 | $37.98M 10-Q · filed 2021-08-09 | $53.92M derived: sum of 3 quarters · filed 2021-08-09 | $64.59M derived: sum of 4 quarters · filed 2021-08-09 |
| 2020-03-31 | $18.57M 10-Q · filed 2021-05-06 | $34.51M derived: sum of 2 quarters · filed 2021-05-06 | $45.18M derived: sum of 3 quarters · filed 2021-05-06 | $55.71M derived: sum of 4 quarters · filed 2021-05-06 |
| 2019-12-31 | $15.94M 10-K · filed 2021-03-30 | $26.61M derived: sum of 2 quarters · filed 2021-03-30 | $37.14M derived: sum of 3 quarters · filed 2021-03-30 | $44.50M 10-K · filed 2022-03-29 |
| 2019-09-30 | $10.67M 10-K · filed 2021-03-30 | $21.20M derived: sum of 2 quarters · filed 2021-03-30 | $28.56M 10-Q · filed 2020-11-05 | $37.61M derived: sum of 4 quarters · filed 2021-03-30 |
| 2019-06-30 | $10.53M 10-K · filed 2021-03-30 | $17.89M 10-Q · filed 2020-08-06 | $26.93M derived: sum of 3 quarters · filed 2021-03-30 | $33.48M derived: sum of 4 quarters · filed 2021-03-30 |
| 2019-03-31 | $7.36M 10-K · filed 2021-03-30 | $16.40M derived: sum of 2 quarters · filed 2021-03-30 | $22.95M derived: sum of 3 quarters · filed 2021-03-30 | $27.19M derived: sum of 4 quarters · filed 2021-03-30 |
| 2018-12-31 | $9.05M 10-K · filed 2020-03-26 | $15.59M derived: sum of 2 quarters · filed 2020-03-26 | $19.84M derived: sum of 3 quarters · filed 2020-03-26 | $22.79M 10-K · filed 2021-03-30 |
| 2018-09-30 | $6.54M 10-K · filed 2020-03-26 | $10.79M derived: sum of 2 quarters · filed 2020-03-26 | $13.74M 10-Q · filed 2019-11-07 | |
| 2018-06-30 | $4.24M 10-K · filed 2020-03-26 | $7.20M derived: sum of 2 quarters · filed 2020-03-26 | ||
| 2018-03-31 | $2.96M 10-K · filed 2020-03-26 | |||
| 2017-12-31 | $11.15M 10-K · filed 2020-03-26 |